Síndrome inflamatorio multisistémico en niños relacionados con el SARS-CoV-2

1. McArdle AJ, Vito O, Patel H, et al; BATS Consortium. Treatment of multisystem inflammatory syndrome in children. N Engl J Med. 2021;385:11–22.
2. Payne AB, Gilani Z, Godfred-Cato S, et al; MIS-C Incidence Authorship Group. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw Open. 2021;4:e2116420.
3. Feldstein LR, Rose EB, Horwitz SM, et al; Overcoming COVID-19 Investigators; Centers for Disease Control and Prevention COVID-19 Response Team. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334–346.
4. Feldstein LR, Tenforde MW, Friedman KG, et al; Overcoming COVID-19 Investigators. Characteristics and outcomes of us children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325:1074– 1087.
5. LaRovere KL, Riggs BJ, Poussaint TY, et al; Overcoming COVID-19 Investigators. Neurologic
involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536–547.
6. Whitworth H, Sartain SE, Kumar R, et al. Rate of thrombosis in children and adolescents hospitalized with COV